{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:40Z","timestamp":1791862240272,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"DOI":"10.1007\/s11739-026-04414-x","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:25:15Z","timestamp":1780935915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenobarbital monotherapy vs benzodiazepines for alcohol withdrawal syndrome: a multicenter propensity-matched comparative effectiveness study"],"prefix":"10.1007","author":[{"given":"Dominique R.","family":"Grayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara E.","family":"Rieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Nasrullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Pei","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palwasha","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0256-4272","authenticated-orcid":false,"given":"Humza","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Baker","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"2","key":"4414_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jama.278.2.144","volume":"278","author":"MF Mayo-Smith","year":"1997","unstructured":"Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278(2):144\u2013151. https:\/\/doi.org\/10.1001\/jama.278.2.144","journal-title":"JAMA"},{"issue":"18","key":"4414_CR2","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra020617","volume":"348","author":"TR Kosten","year":"2003","unstructured":"Kosten TR, O\u2019Connor PG (2003) Management of drug and alcohol withdrawal. N Engl J Med 348(18):1786\u20131795. https:\/\/doi.org\/10.1056\/NEJMra020617","journal-title":"N Engl J Med"},{"issue":"11","key":"4414_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84(11):1353\u20131357. https:\/\/doi.org\/10.1111\/j.1360-0443.1989.tb00737.x","journal-title":"Br J Addict"},{"key":"4414_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajem.2025.03.008","volume":"92","author":"XJC Cheng","year":"2025","unstructured":"Cheng XJC, Chung J, Yoo N et al (2025) Impact of phenobarbital when used in combination with benzodiazepines for the treatment of alcohol withdrawal syndrome: a retrospective analysis. Am J Emerg Med 92:79\u201384. https:\/\/doi.org\/10.1016\/j.ajem.2025.03.008","journal-title":"Am J Emerg Med"},{"issue":"3","key":"4414_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","volume":"44","author":"J Rosenson","year":"2013","unstructured":"Rosenson J, Clements C, Simon B et al (2013) Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med 44(3):592-598.e2. https:\/\/doi.org\/10.1016\/j.jemermed.2012.07.056","journal-title":"J Emerg Med"},{"issue":"9","key":"4414_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202203-0466LE","volume":"206","author":"NA Bosch","year":"2022","unstructured":"Bosch NA, Law AC, Walkey AJ (2022) Phenobarbital for severe alcohol withdrawal syndrome: a multicenter retrospective cohort study. Am J Respir Crit Care Med 206(9):1171\u20131174. https:\/\/doi.org\/10.1164\/rccm.202203-0466LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"4414_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.psym.2019.02.002","volume":"60","author":"M Nisavic","year":"2019","unstructured":"Nisavic M, Nejad SH, Isenberg BM et al (2019) Use of phenobarbital in alcohol withdrawal management - a retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients. Psychosomatics 60(5):458\u2013467. https:\/\/doi.org\/10.1016\/j.psym.2019.02.002","journal-title":"Psychosomatics"},{"issue":"9","key":"4414_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0885066618783947","volume":"35","author":"M Oks","year":"2020","unstructured":"Oks M, Cleven KL, Healy L et al (2020) The safety and utility of phenobarbital use for the treatment of severe alcohol withdrawal syndrome in the Medical Intensive Care Unit. J Intensive Care Med 35(9):844\u2013850. https:\/\/doi.org\/10.1177\/0885066618783947","journal-title":"J Intensive Care Med"},{"issue":"2","key":"4414_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/08971900241273144","volume":"38","author":"M Ingebrigtson","year":"2025","unstructured":"Ingebrigtson M, Schang S, Hyzy RC et al (2025) Phenobarbital versus benzodiazepines for alcohol withdrawal in the Medical Intensive Care Unit (ICU): a retrospective cohort study. J Pharm Pract 38(2):231\u2013236. https:\/\/doi.org\/10.1177\/08971900241273144","journal-title":"J Pharm Pract"},{"issue":"9","key":"4414_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/10600280231221241","volume":"58","author":"KM Kessel","year":"2024","unstructured":"Kessel KM, Olson LM, Kruse DA et al (2024) Phenobarbital versus benzodiazepines for the treatment of severe alcohol withdrawal. Ann Pharmacother 58(9):877\u2013885. https:\/\/doi.org\/10.1177\/10600280231221241","journal-title":"Ann Pharmacother"},{"issue":"9","key":"4414_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0018578717720310","volume":"52","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Rowe JM, Wong A, Wiley TL, Lee KC, Kane-Gill SL (2017) Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review. Hosp Pharm 52(9):607\u2013616. https:\/\/doi.org\/10.1177\/0018578717720310","journal-title":"Hosp Pharm"},{"issue":"4","key":"4414_CR12","doi-asserted-by":"publisher","first-page":"A4606","DOI":"10.1016\/j.chest.2025.07.2581","volume":"168","author":"T Moldovan","year":"2025","unstructured":"Moldovan T, Raja U, Ellena K, Schmidt K, Dari S, Anderson A (2025) Barriers to the use of phenobarbital for acute alcohol withdrawal: a QI project. Chest 168(4):A4606\u2013A4607. https:\/\/doi.org\/10.1016\/j.chest.2025.07.2581","journal-title":"Chest"},{"key":"4414_CR13","unstructured":"TriNetX | Connecting the world to improve human health. TriNetX. https:\/\/trinetx.com\/about-trinetx\/. Accessed 21 Aug 2025"},{"issue":"2","key":"4414_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/10600280251340164","volume":"60","author":"TM Law","year":"2026","unstructured":"Law TM, Roper SL, McKinney A et al (2026) Evaluation of symptom-triggered benzodiazepines versus phenobarbital for alcohol withdrawal syndrome in trauma-surgical intensive care patients. Ann Pharmacother 60(2):105\u2013114. https:\/\/doi.org\/10.1177\/10600280251340164","journal-title":"Ann Pharmacother"},{"key":"4414_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/10600280251383490","author":"T Le","year":"2025","unstructured":"Le T, Staas S, Firmin R et al (2025) Evaluation of phenobarbital loading dose in reducing cumulative benzodiazepine utilization in patients with alcohol withdrawal syndrome. Ann Pharmacother. https:\/\/doi.org\/10.1177\/10600280251383490","journal-title":"Ann Pharmacother"},{"issue":"Supplement_1","key":"4414_CR16","doi-asserted-by":"publisher","first-page":"A7373","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7373","volume":"211","author":"TL Steel","year":"2025","unstructured":"Steel TL, Wolpaw BJ (2025) Improving care beyond the ICU \u2013 implementation, effectiveness, and safety outcomes pre- vs. post-implementation of a phenobarbital order set for alcohol withdrawal syndrome in all hospital locations. Am J Respir Crit Care Med 211(Supplement_1):A7373. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A7373","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4414_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.28694","volume":"8","author":"BJ Wolpaw","year":"2025","unstructured":"Wolpaw BJ, Oren H, Quinnan-Hostein L et al (2025) Hospital-wide implementation, clinical outcomes, and safety of phenobarbital for alcohol withdrawal. JAMA Netw Open 8(8):e2528694. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.28694","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4414_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000898","volume":"5","author":"M Alwakeel","year":"2023","unstructured":"Alwakeel M, Alayan D, Saleem T et al (2023) Phenobarbital-based protocol for alcohol withdrawal syndrome in a medical ICU: pre-post implementation study. Crit Care Explor 5(4):e0898. https:\/\/doi.org\/10.1097\/CCE.0000000000000898","journal-title":"Crit Care Explor"},{"issue":"4","key":"4414_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/npr2.12347","volume":"43","author":"D Malone","year":"2023","unstructured":"Malone D, Costin BN, MacElroy D, Al-Hegelan M, Thompson J, Bronshteyn Y (2023) Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome. Neuropsychopharmacol Rep 43(4):532\u2013541. https:\/\/doi.org\/10.1002\/npr2.12347","journal-title":"Neuropsychopharmacol Rep"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04414-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:25:20Z","timestamp":1780935920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04414-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":19,"alternative-id":["4414"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04414-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no relevant financial or non-financial conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for this study, as all analyses were conducted using aggregate, de-identified data in accordance with applicable regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was conducted using de-identifi ed electronic health record data obtained from the TriNetX Research Network. The TriNetX platform provides only de-identified patient data in compliance with applicable privacy regulations. No direct patient contact or intervention occurred, and no animals were involved in this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Because the study utilized de-identified data and did not involve direct interaction with human participants, informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}